ANRO Should I Buy

BUY (starter position now). At ~$16.75 pre-market, ANRO is trading just above key support (S1 ~16.14) with bullish longer-term moving averages (SMA_5 > SMA_20 > SMA_200) and strongly bullish options positioning (very low put/call). Wall Street is broadly constructive with multiple recent price-target raises and a catalyst-rich 2026 setup. Despite weak current fundamentals (pre-revenue, widening losses) and notable hedge-fund selling, the combination of technical base near support + bullish derivatives sentiment + clear upcoming clinical catalysts makes it a good buy right now for a beginner long-term investor who doesn’t want to wait for a “perfect” entry. Practical approach: initiate a partial position now and reserve remaining capital for potential add-ons around support (~16.1–15.5) if it dips.

Trend/price location: Pre-market ~16.75, below pivot 17.129 and between S1 16.136 and R1 18.122—suggesting a near-term range with support nearby. Momentum: MACD histogram -0.15 (below 0) but negatively contracting, which often signals downside momentum is fading. RSI: RSI_6 ~47.7 (neutral), consistent with consolidation rather than an overbought/oversold extreme. Moving averages: Bullish structure (SMA_5 > SMA_20 > SMA_200) supports a constructive intermediate/longer-term trend. Key levels: Support 16.14 then 15.52; Resistance 17.13 then 18.12/18.74. Pattern-based odds (provided): ~60% chance of modest upside: +0.24% next day, +1.45% next week, +3.92% next month.